Skip to content
Home/Companies/Biotech/BioAscent
BioAscent

BioAscent

Biotech·UK·Active·8yr hold
Entry
2018
Hold
8yr
Status
Active

Who owns BioAscent?

BioAscent is currently owned by Maven Capital Partners through Maven Income and Growth VCT 4 (2004 vintage), since 2018.

Hand-verified · updated 2026-06-01

Maven Capital Partners
Investor
Maven Capital Partners
Maven Income and Growth VCT 4 · 2004 · Evergreen

Key facts

HQUK
SectorBiotech
StatusActive
Websitewww.bioascent.com

More from Maven Income and Growth VCT 4

Other portfolio companies in the same fund.

FITR
FITR
Active
HealthTechUK· 2025
Novatus Global
Exited 2024
SaaSUK· 2022
to
Blacktrace Group
Exited 2023
MedTechUK· 2016
to

More Maven Capital Partners portfolio companies

From the same investor, across funds.

Chorus Intelligence
Chorus Intelligence
Active
SoftwareUK· 2026
Calatherm
Active
IndustrialsUK· 2025
Digital Rewards Group
Digital Rewards Group
Active
SoftwareUK· 2025
KubeNet
KubeNet
Active
IT ServicesUK· 2025
Covestus
Active
HealthcareUK· 2024
Manufacture 2030
Active
ClimateTechUK· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track BioAscent

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on BioAscent.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue